We studied the effect of
chemical sympathectomy by
6-hydroxydopamine (6-OHDA) on
pain behavior and alpha(2)-adrenergic antinociception in rats with a spinal nerve
ligation-induced neuropathy. For assessment of alpha(2)-adrenergic antinociception, the rats were treated systemically with two alpha(2)-adrenoceptor agonists, one of which only poorly (MPV-2426) and the other very well (
dexmedetomidine) penetrates the blood-brain barrier. Moreover, the effect of
MPV-2426 on spontaneous activity of dorsal root nerve fibers proximal to the nerve injury was determined. Systemic treatment with
6-OHDA produced a marked decrease in immunocytochemical labeling of sympathetic nerve fibers in the skin but it produced no marked change in basal
pain sensitivity to mechanical stimulation either in neuropathic or
sham-operated animals. Systemic administration of
MPV-2426 and
dexmedetomidine produced a dose-dependent tactile antiallodynic effect in neuropathic animals. Intraplantar injection of
MPV-2426 had an identical antiallodynic effect independent of whether it was injected into the neuropathic or contralateral hindpaw. In a test of mechanical nociception and
hyperalgesia,
dexmedetomidine markedly attenuated
pain responses in all experimental groups, whereas
MPV-2426 had a weak but significant
pain attenuating effect only in neuropathic animals. In the tail flick test, both alpha(2)-adrenoceptor agonists had a significant antinociceptive effect. The
pain attenuating effect of
MPV-2426 was enhanced by pretreatment with
6-OHDA, except in a test of
tactile allodynia. MPV-2426-induced modulation of spontaneous activity was not a general property of dorsal root fibers proximal to the injury. The results indicate that a chemical destruction of sympathetic postganglionic nerve fibers innervating the skin does not markedly influence cutaneous
pain sensitivity nor is it critical for the alpha(2)-adrenoceptor agonist-induced attenuation of
pain behavior in neuropathic or non-neuropathic animals.
Chemical sympathectomy, independent of neuropathy, enhanced the
pain attenuating effect by
MPV-2426, probably due to a peripheral action, whereas in non-sympathectomized control and neuropathic animals peripheral mechanisms have only a minor, if any, role in the alpha(2)-adrenoceptor agonist-induced antinociception.